nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—CNR1—multiple sclerosis	0.518	1	CbGaD
Dronabinol—ABCG2—Cladribine—multiple sclerosis	0.0489	0.136	CbGbCtD
Dronabinol—ABCG2—Mitoxantrone—multiple sclerosis	0.0357	0.0991	CbGbCtD
Dronabinol—CYP2A6—Prednisolone—multiple sclerosis	0.0339	0.0942	CbGbCtD
Dronabinol—CYP2A6—Dexamethasone—multiple sclerosis	0.02	0.0555	CbGbCtD
Dronabinol—ABCG2—Dexamethasone—multiple sclerosis	0.0185	0.0514	CbGbCtD
Dronabinol—ABCB1—Methylprednisolone—multiple sclerosis	0.0176	0.049	CbGbCtD
Dronabinol—CYP1A1—Dexamethasone—multiple sclerosis	0.0171	0.0474	CbGbCtD
Dronabinol—CYP3A4—Fingolimod—multiple sclerosis	0.0164	0.0455	CbGbCtD
Dronabinol—ABCG2—Methotrexate—multiple sclerosis	0.0149	0.0413	CbGbCtD
Dronabinol—CYP2C19—Prednisone—multiple sclerosis	0.0132	0.0368	CbGbCtD
Dronabinol—ABCB1—Mitoxantrone—multiple sclerosis	0.0129	0.0357	CbGbCtD
Dronabinol—ABCB1—Betamethasone—multiple sclerosis	0.0115	0.0319	CbGbCtD
Dronabinol—ABCB1—Prednisolone—multiple sclerosis	0.0113	0.0314	CbGbCtD
Dronabinol—ABCB1—Prednisone—multiple sclerosis	0.0107	0.0297	CbGbCtD
Dronabinol—CYP3A4—Methylprednisolone—multiple sclerosis	0.0106	0.0293	CbGbCtD
Dronabinol—CYP2C19—Dexamethasone—multiple sclerosis	0.00827	0.023	CbGbCtD
Dronabinol—CYP3A4—Triamcinolone—multiple sclerosis	0.00801	0.0222	CbGbCtD
Dronabinol—CYP3A4—Mitoxantrone—multiple sclerosis	0.00771	0.0214	CbGbCtD
Dronabinol—CYP2C9—Dexamethasone—multiple sclerosis	0.00687	0.0191	CbGbCtD
Dronabinol—CYP3A4—Betamethasone—multiple sclerosis	0.00687	0.0191	CbGbCtD
Dronabinol—CYP3A4—Prednisolone—multiple sclerosis	0.00678	0.0188	CbGbCtD
Dronabinol—ABCB1—Dexamethasone—multiple sclerosis	0.00667	0.0185	CbGbCtD
Dronabinol—CYP3A4—Prednisone—multiple sclerosis	0.0064	0.0178	CbGbCtD
Dronabinol—Nabilone—CNR1—multiple sclerosis	0.00604	1	CrCbGaD
Dronabinol—ABCB1—Methotrexate—multiple sclerosis	0.00536	0.0149	CbGbCtD
Dronabinol—CYP3A4—Dexamethasone—multiple sclerosis	0.004	0.0111	CbGbCtD
Dronabinol—Tachycardia—Cladribine—multiple sclerosis	0.000289	0.00545	CcSEcCtD
Dronabinol—Skin disorder—Cladribine—multiple sclerosis	0.000288	0.00543	CcSEcCtD
Dronabinol—Sinusitis—Mitoxantrone—multiple sclerosis	0.000286	0.0054	CcSEcCtD
Dronabinol—Hyperhidrosis—Cladribine—multiple sclerosis	0.000286	0.0054	CcSEcCtD
Dronabinol—Anorexia—Cladribine—multiple sclerosis	0.000282	0.00533	CcSEcCtD
Dronabinol—Euphoric mood—Prednisone—multiple sclerosis	0.000279	0.00527	CcSEcCtD
Dronabinol—Hypotension—Cladribine—multiple sclerosis	0.000277	0.00522	CcSEcCtD
Dronabinol—Rhinitis—Mitoxantrone—multiple sclerosis	0.000275	0.00518	CcSEcCtD
Dronabinol—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000274	0.00517	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00027	0.00509	CcSEcCtD
Dronabinol—Malaise—Azathioprine—multiple sclerosis	0.000266	0.00502	CcSEcCtD
Dronabinol—Somnolence—Cladribine—multiple sclerosis	0.000263	0.00497	CcSEcCtD
Dronabinol—Decreased appetite—Cladribine—multiple sclerosis	0.000257	0.00486	CcSEcCtD
Dronabinol—Fatigue—Cladribine—multiple sclerosis	0.000255	0.00482	CcSEcCtD
Dronabinol—Amnesia—Prednisone—multiple sclerosis	0.000251	0.00474	CcSEcCtD
Dronabinol—Myalgia—Azathioprine—multiple sclerosis	0.000251	0.00474	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000249	0.00471	CcSEcCtD
Dronabinol—Discomfort—Azathioprine—multiple sclerosis	0.000248	0.00468	CcSEcCtD
Dronabinol—Chills—Mitoxantrone—multiple sclerosis	0.000246	0.00464	CcSEcCtD
Dronabinol—Feeling abnormal—Cladribine—multiple sclerosis	0.000244	0.00461	CcSEcCtD
Dronabinol—Conjunctivitis—Prednisolone—multiple sclerosis	0.000243	0.00459	CcSEcCtD
Dronabinol—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000242	0.00457	CcSEcCtD
Dronabinol—Abdominal pain—Cladribine—multiple sclerosis	0.000234	0.00442	CcSEcCtD
Dronabinol—Skin disorder—Azathioprine—multiple sclerosis	0.000234	0.00441	CcSEcCtD
Dronabinol—Hypotension—Azathioprine—multiple sclerosis	0.000225	0.00425	CcSEcCtD
Dronabinol—Conjunctivitis—Triamcinolone—multiple sclerosis	0.000224	0.00422	CcSEcCtD
Dronabinol—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000221	0.00418	CcSEcCtD
Dronabinol—Sweating—Methylprednisolone—multiple sclerosis	0.00022	0.00416	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000219	0.00414	CcSEcCtD
Dronabinol—Hypersensitivity—Cladribine—multiple sclerosis	0.000218	0.00412	CcSEcCtD
Dronabinol—Malaise—Mitoxantrone—multiple sclerosis	0.000215	0.00406	CcSEcCtD
Dronabinol—Asthenia—Cladribine—multiple sclerosis	0.000212	0.00401	CcSEcCtD
Dronabinol—Pruritus—Cladribine—multiple sclerosis	0.00021	0.00395	CcSEcCtD
Dronabinol—Cough—Mitoxantrone—multiple sclerosis	0.000208	0.00393	CcSEcCtD
Dronabinol—Rhinitis—Triamcinolone—multiple sclerosis	0.000207	0.00391	CcSEcCtD
Dronabinol—Rhinitis—Methylprednisolone—multiple sclerosis	0.000207	0.0039	CcSEcCtD
Dronabinol—Convulsion—Mitoxantrone—multiple sclerosis	0.000207	0.0039	CcSEcCtD
Dronabinol—Hallucination—Methylprednisolone—multiple sclerosis	0.000205	0.00387	CcSEcCtD
Dronabinol—Conjunctivitis—Betamethasone—multiple sclerosis	0.000203	0.00383	CcSEcCtD
Dronabinol—Conjunctivitis—Dexamethasone—multiple sclerosis	0.000203	0.00383	CcSEcCtD
Dronabinol—Myalgia—Mitoxantrone—multiple sclerosis	0.000203	0.00383	CcSEcCtD
Dronabinol—Diarrhoea—Cladribine—multiple sclerosis	0.000203	0.00382	CcSEcCtD
Dronabinol—Anxiety—Mitoxantrone—multiple sclerosis	0.000202	0.00382	CcSEcCtD
Dronabinol—Discomfort—Mitoxantrone—multiple sclerosis	0.000201	0.00379	CcSEcCtD
Dronabinol—Feeling abnormal—Azathioprine—multiple sclerosis	0.000198	0.00374	CcSEcCtD
Dronabinol—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000197	0.00372	CcSEcCtD
Dronabinol—Confusional state—Mitoxantrone—multiple sclerosis	0.000196	0.0037	CcSEcCtD
Dronabinol—Dizziness—Cladribine—multiple sclerosis	0.000196	0.0037	CcSEcCtD
Dronabinol—Abdominal pain—Azathioprine—multiple sclerosis	0.00019	0.00359	CcSEcCtD
Dronabinol—Tachycardia—Mitoxantrone—multiple sclerosis	0.00019	0.00359	CcSEcCtD
Dronabinol—Skin disorder—Mitoxantrone—multiple sclerosis	0.000189	0.00357	CcSEcCtD
Dronabinol—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000188	0.00355	CcSEcCtD
Dronabinol—Rash—Cladribine—multiple sclerosis	0.000187	0.00352	CcSEcCtD
Dronabinol—Hallucination—Dexamethasone—multiple sclerosis	0.000187	0.00352	CcSEcCtD
Dronabinol—Hallucination—Betamethasone—multiple sclerosis	0.000187	0.00352	CcSEcCtD
Dronabinol—Dermatitis—Cladribine—multiple sclerosis	0.000187	0.00352	CcSEcCtD
Dronabinol—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000186	0.00352	CcSEcCtD
Dronabinol—Anorexia—Mitoxantrone—multiple sclerosis	0.000186	0.0035	CcSEcCtD
Dronabinol—Ataxia—Methotrexate—multiple sclerosis	0.000186	0.0035	CcSEcCtD
Dronabinol—Headache—Cladribine—multiple sclerosis	0.000186	0.0035	CcSEcCtD
Dronabinol—Hypotension—Mitoxantrone—multiple sclerosis	0.000182	0.00343	CcSEcCtD
Dronabinol—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000182	0.00343	CcSEcCtD
Dronabinol—Depression—Prednisone—multiple sclerosis	0.000181	0.00342	CcSEcCtD
Dronabinol—Hypersensitivity—Azathioprine—multiple sclerosis	0.000177	0.00335	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000177	0.00335	CcSEcCtD
Dronabinol—Malaise—Prednisolone—multiple sclerosis	0.000176	0.00333	CcSEcCtD
Dronabinol—Somnolence—Mitoxantrone—multiple sclerosis	0.000173	0.00327	CcSEcCtD
Dronabinol—Convulsion—Prednisolone—multiple sclerosis	0.00017	0.0032	CcSEcCtD
Dronabinol—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000169	0.00319	CcSEcCtD
Dronabinol—Fatigue—Mitoxantrone—multiple sclerosis	0.000168	0.00317	CcSEcCtD
Dronabinol—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000167	0.00315	CcSEcCtD
Dronabinol—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000167	0.00314	CcSEcCtD
Dronabinol—Diarrhoea—Azathioprine—multiple sclerosis	0.000165	0.00311	CcSEcCtD
Dronabinol—Discomfort—Prednisolone—multiple sclerosis	0.000165	0.00311	CcSEcCtD
Dronabinol—Hallucination—Prednisone—multiple sclerosis	0.000163	0.00307	CcSEcCtD
Dronabinol—Malaise—Triamcinolone—multiple sclerosis	0.000162	0.00306	CcSEcCtD
Dronabinol—Malaise—Methylprednisolone—multiple sclerosis	0.000162	0.00306	CcSEcCtD
Dronabinol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00016	0.00303	CcSEcCtD
Dronabinol—Dizziness—Azathioprine—multiple sclerosis	0.000159	0.00301	CcSEcCtD
Dronabinol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000159	0.003	CcSEcCtD
Dronabinol—Cough—Triamcinolone—multiple sclerosis	0.000157	0.00296	CcSEcCtD
Dronabinol—Convulsion—Triamcinolone—multiple sclerosis	0.000156	0.00294	CcSEcCtD
Dronabinol—Tachycardia—Prednisolone—multiple sclerosis	0.000156	0.00294	CcSEcCtD
Dronabinol—Convulsion—Methylprednisolone—multiple sclerosis	0.000156	0.00294	CcSEcCtD
Dronabinol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000154	0.00291	CcSEcCtD
Dronabinol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000154	0.0029	CcSEcCtD
Dronabinol—Myalgia—Triamcinolone—multiple sclerosis	0.000153	0.00289	CcSEcCtD
Dronabinol—Myalgia—Methylprednisolone—multiple sclerosis	0.000153	0.00288	CcSEcCtD
Dronabinol—Anxiety—Methylprednisolone—multiple sclerosis	0.000152	0.00287	CcSEcCtD
Dronabinol—Drowsiness—Methotrexate—multiple sclerosis	0.000152	0.00287	CcSEcCtD
Dronabinol—Rash—Azathioprine—multiple sclerosis	0.000152	0.00287	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000152	0.00286	CcSEcCtD
Dronabinol—Dermatitis—Azathioprine—multiple sclerosis	0.000152	0.00286	CcSEcCtD
Dronabinol—Depression—Methotrexate—multiple sclerosis	0.000152	0.00286	CcSEcCtD
Dronabinol—Flushing—Prednisone—multiple sclerosis	0.000152	0.00286	CcSEcCtD
Dronabinol—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000151	0.00286	CcSEcCtD
Dronabinol—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000151	0.00286	CcSEcCtD
Dronabinol—Discomfort—Triamcinolone—multiple sclerosis	0.000151	0.00286	CcSEcCtD
Dronabinol—Discomfort—Methylprednisolone—multiple sclerosis	0.000151	0.00285	CcSEcCtD
Dronabinol—Headache—Azathioprine—multiple sclerosis	0.000151	0.00285	CcSEcCtD
Dronabinol—Dry mouth—Triamcinolone—multiple sclerosis	0.00015	0.00283	CcSEcCtD
Dronabinol—Conjunctivitis—Methotrexate—multiple sclerosis	0.000148	0.00279	CcSEcCtD
Dronabinol—Confusional state—Methylprednisolone—multiple sclerosis	0.000148	0.00279	CcSEcCtD
Dronabinol—Immune system disorder—Prednisone—multiple sclerosis	0.000148	0.00278	CcSEcCtD
Dronabinol—Malaise—Dexamethasone—multiple sclerosis	0.000147	0.00278	CcSEcCtD
Dronabinol—Malaise—Betamethasone—multiple sclerosis	0.000147	0.00278	CcSEcCtD
Dronabinol—Sweating—Methotrexate—multiple sclerosis	0.000146	0.00275	CcSEcCtD
Dronabinol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000144	0.00271	CcSEcCtD
Dronabinol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000143	0.00271	CcSEcCtD
Dronabinol—Tachycardia—Triamcinolone—multiple sclerosis	0.000143	0.0027	CcSEcCtD
Dronabinol—Tachycardia—Methylprednisolone—multiple sclerosis	0.000143	0.0027	CcSEcCtD
Dronabinol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000142	0.00269	CcSEcCtD
Dronabinol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000142	0.00268	CcSEcCtD
Dronabinol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000142	0.00267	CcSEcCtD
Dronabinol—Convulsion—Dexamethasone—multiple sclerosis	0.000141	0.00267	CcSEcCtD
Dronabinol—Convulsion—Betamethasone—multiple sclerosis	0.000141	0.00267	CcSEcCtD
Dronabinol—Asthenia—Mitoxantrone—multiple sclerosis	0.00014	0.00264	CcSEcCtD
Dronabinol—Myalgia—Betamethasone—multiple sclerosis	0.000139	0.00262	CcSEcCtD
Dronabinol—Myalgia—Dexamethasone—multiple sclerosis	0.000139	0.00262	CcSEcCtD
Dronabinol—Anxiety—Betamethasone—multiple sclerosis	0.000139	0.00261	CcSEcCtD
Dronabinol—Anxiety—Dexamethasone—multiple sclerosis	0.000139	0.00261	CcSEcCtD
Dronabinol—Discomfort—Dexamethasone—multiple sclerosis	0.000137	0.00259	CcSEcCtD
Dronabinol—Discomfort—Betamethasone—multiple sclerosis	0.000137	0.00259	CcSEcCtD
Dronabinol—Hypotension—Methylprednisolone—multiple sclerosis	0.000137	0.00258	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000134	0.00253	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000133	0.00252	CcSEcCtD
Dronabinol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000133	0.00251	CcSEcCtD
Dronabinol—Ill-defined disorder—Prednisone—multiple sclerosis	0.000132	0.00249	CcSEcCtD
Dronabinol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000132	0.00248	CcSEcCtD
Dronabinol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000131	0.00247	CcSEcCtD
Dronabinol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000131	0.00247	CcSEcCtD
Dronabinol—Tachycardia—Betamethasone—multiple sclerosis	0.00013	0.00245	CcSEcCtD
Dronabinol—Tachycardia—Dexamethasone—multiple sclerosis	0.00013	0.00245	CcSEcCtD
Dronabinol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000129	0.00243	CcSEcCtD
Dronabinol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000129	0.00243	CcSEcCtD
Dronabinol—Malaise—Prednisone—multiple sclerosis	0.000128	0.00242	CcSEcCtD
Dronabinol—Tinnitus—Methotrexate—multiple sclerosis	0.000127	0.0024	CcSEcCtD
Dronabinol—Anorexia—Betamethasone—multiple sclerosis	0.000127	0.0024	CcSEcCtD
Dronabinol—Anorexia—Dexamethasone—multiple sclerosis	0.000127	0.0024	CcSEcCtD
Dronabinol—Fatigue—Triamcinolone—multiple sclerosis	0.000127	0.00239	CcSEcCtD
Dronabinol—Fatigue—Methylprednisolone—multiple sclerosis	0.000126	0.00238	CcSEcCtD
Dronabinol—Hypotension—Dexamethasone—multiple sclerosis	0.000125	0.00235	CcSEcCtD
Dronabinol—Hypotension—Betamethasone—multiple sclerosis	0.000125	0.00235	CcSEcCtD
Dronabinol—Immune system disorder—Methotrexate—multiple sclerosis	0.000123	0.00233	CcSEcCtD
Dronabinol—Convulsion—Prednisone—multiple sclerosis	0.000123	0.00232	CcSEcCtD
Dronabinol—Rash—Mitoxantrone—multiple sclerosis	0.000123	0.00232	CcSEcCtD
Dronabinol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000123	0.00231	CcSEcCtD
Dronabinol—Chills—Methotrexate—multiple sclerosis	0.000122	0.00231	CcSEcCtD
Dronabinol—Headache—Mitoxantrone—multiple sclerosis	0.000122	0.0023	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000121	0.00229	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000121	0.00229	CcSEcCtD
Dronabinol—Myalgia—Prednisone—multiple sclerosis	0.000121	0.00228	CcSEcCtD
Dronabinol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000121	0.00228	CcSEcCtD
Dronabinol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000121	0.00228	CcSEcCtD
Dronabinol—Anxiety—Prednisone—multiple sclerosis	0.000121	0.00228	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00012	0.00227	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00012	0.00226	CcSEcCtD
Dronabinol—Discomfort—Prednisone—multiple sclerosis	0.00012	0.00226	CcSEcCtD
Dronabinol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000118	0.00222	CcSEcCtD
Dronabinol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000116	0.00219	CcSEcCtD
Dronabinol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000116	0.00219	CcSEcCtD
Dronabinol—Decreased appetite—Betamethasone—multiple sclerosis	0.000116	0.00219	CcSEcCtD
Dronabinol—Fatigue—Dexamethasone—multiple sclerosis	0.000115	0.00217	CcSEcCtD
Dronabinol—Fatigue—Betamethasone—multiple sclerosis	0.000115	0.00217	CcSEcCtD
Dronabinol—Nervous system disorder—Prednisone—multiple sclerosis	0.000114	0.00215	CcSEcCtD
Dronabinol—Tachycardia—Prednisone—multiple sclerosis	0.000113	0.00214	CcSEcCtD
Dronabinol—Skin disorder—Prednisone—multiple sclerosis	0.000113	0.00213	CcSEcCtD
Dronabinol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000112	0.00212	CcSEcCtD
Dronabinol—Anorexia—Prednisone—multiple sclerosis	0.000111	0.00209	CcSEcCtD
Dronabinol—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00011	0.00208	CcSEcCtD
Dronabinol—Feeling abnormal—Betamethasone—multiple sclerosis	0.00011	0.00207	CcSEcCtD
Dronabinol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00011	0.00207	CcSEcCtD
Dronabinol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000109	0.00206	CcSEcCtD
Dronabinol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000109	0.00206	CcSEcCtD
Dronabinol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000108	0.00204	CcSEcCtD
Dronabinol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000108	0.00204	CcSEcCtD
Dronabinol—Malaise—Methotrexate—multiple sclerosis	0.000107	0.00202	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000106	0.002	CcSEcCtD
Dronabinol—Dizziness—Prednisolone—multiple sclerosis	0.000106	0.00199	CcSEcCtD
Dronabinol—Asthenia—Triamcinolone—multiple sclerosis	0.000105	0.00199	CcSEcCtD
Dronabinol—Abdominal pain—Dexamethasone—multiple sclerosis	0.000105	0.00199	CcSEcCtD
Dronabinol—Abdominal pain—Betamethasone—multiple sclerosis	0.000105	0.00199	CcSEcCtD
Dronabinol—Asthenia—Methylprednisolone—multiple sclerosis	0.000105	0.00198	CcSEcCtD
Dronabinol—Pruritus—Triamcinolone—multiple sclerosis	0.000104	0.00196	CcSEcCtD
Dronabinol—Cough—Methotrexate—multiple sclerosis	0.000104	0.00196	CcSEcCtD
Dronabinol—Pruritus—Methylprednisolone—multiple sclerosis	0.000104	0.00196	CcSEcCtD
Dronabinol—Convulsion—Methotrexate—multiple sclerosis	0.000103	0.00194	CcSEcCtD
Dronabinol—Myalgia—Methotrexate—multiple sclerosis	0.000101	0.00191	CcSEcCtD
Dronabinol—Decreased appetite—Prednisone—multiple sclerosis	0.000101	0.0019	CcSEcCtD
Dronabinol—Rash—Prednisolone—multiple sclerosis	0.000101	0.0019	CcSEcCtD
Dronabinol—Dermatitis—Prednisolone—multiple sclerosis	0.000101	0.0019	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.0001	0.0019	CcSEcCtD
Dronabinol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0001	0.00189	CcSEcCtD
Dronabinol—Fatigue—Prednisone—multiple sclerosis	0.0001	0.00189	CcSEcCtD
Dronabinol—Headache—Prednisolone—multiple sclerosis	0.0001	0.00189	CcSEcCtD
Dronabinol—Discomfort—Methotrexate—multiple sclerosis	0.0001	0.00189	CcSEcCtD
Dronabinol—Confusional state—Methotrexate—multiple sclerosis	9.78e-05	0.00185	CcSEcCtD
Dronabinol—Dizziness—Triamcinolone—multiple sclerosis	9.71e-05	0.00183	CcSEcCtD
Dronabinol—Dizziness—Methylprednisolone—multiple sclerosis	9.69e-05	0.00183	CcSEcCtD
Dronabinol—Feeling abnormal—Prednisone—multiple sclerosis	9.56e-05	0.0018	CcSEcCtD
Dronabinol—Asthenia—Betamethasone—multiple sclerosis	9.56e-05	0.0018	CcSEcCtD
Dronabinol—Asthenia—Dexamethasone—multiple sclerosis	9.56e-05	0.0018	CcSEcCtD
Dronabinol—Nervous system disorder—Methotrexate—multiple sclerosis	9.51e-05	0.00179	CcSEcCtD
Dronabinol—Gastrointestinal pain—Prednisone—multiple sclerosis	9.49e-05	0.00179	CcSEcCtD
Dronabinol—Pruritus—Betamethasone—multiple sclerosis	9.43e-05	0.00178	CcSEcCtD
Dronabinol—Pruritus—Dexamethasone—multiple sclerosis	9.43e-05	0.00178	CcSEcCtD
Dronabinol—Skin disorder—Methotrexate—multiple sclerosis	9.42e-05	0.00178	CcSEcCtD
Dronabinol—Hyperhidrosis—Methotrexate—multiple sclerosis	9.38e-05	0.00177	CcSEcCtD
Dronabinol—Rash—Triamcinolone—multiple sclerosis	9.26e-05	0.00175	CcSEcCtD
Dronabinol—Dermatitis—Triamcinolone—multiple sclerosis	9.25e-05	0.00175	CcSEcCtD
Dronabinol—Anorexia—Methotrexate—multiple sclerosis	9.24e-05	0.00174	CcSEcCtD
Dronabinol—Rash—Methylprednisolone—multiple sclerosis	9.24e-05	0.00174	CcSEcCtD
Dronabinol—Dermatitis—Methylprednisolone—multiple sclerosis	9.23e-05	0.00174	CcSEcCtD
Dronabinol—Headache—Triamcinolone—multiple sclerosis	9.2e-05	0.00174	CcSEcCtD
Dronabinol—Headache—Methylprednisolone—multiple sclerosis	9.18e-05	0.00173	CcSEcCtD
Dronabinol—Abdominal pain—Prednisone—multiple sclerosis	9.17e-05	0.00173	CcSEcCtD
Dronabinol—Diarrhoea—Dexamethasone—multiple sclerosis	9.12e-05	0.00172	CcSEcCtD
Dronabinol—Diarrhoea—Betamethasone—multiple sclerosis	9.12e-05	0.00172	CcSEcCtD
Dronabinol—Hypotension—Methotrexate—multiple sclerosis	9.06e-05	0.00171	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.84e-05	0.00167	CcSEcCtD
Dronabinol—Dizziness—Betamethasone—multiple sclerosis	8.81e-05	0.00166	CcSEcCtD
Dronabinol—Dizziness—Dexamethasone—multiple sclerosis	8.81e-05	0.00166	CcSEcCtD
Dronabinol—Somnolence—Methotrexate—multiple sclerosis	8.62e-05	0.00163	CcSEcCtD
Dronabinol—Hypersensitivity—Prednisone—multiple sclerosis	8.55e-05	0.00161	CcSEcCtD
Dronabinol—Decreased appetite—Methotrexate—multiple sclerosis	8.43e-05	0.00159	CcSEcCtD
Dronabinol—Rash—Dexamethasone—multiple sclerosis	8.4e-05	0.00159	CcSEcCtD
Dronabinol—Rash—Betamethasone—multiple sclerosis	8.4e-05	0.00159	CcSEcCtD
Dronabinol—Dermatitis—Dexamethasone—multiple sclerosis	8.39e-05	0.00158	CcSEcCtD
Dronabinol—Dermatitis—Betamethasone—multiple sclerosis	8.39e-05	0.00158	CcSEcCtD
Dronabinol—Fatigue—Methotrexate—multiple sclerosis	8.36e-05	0.00158	CcSEcCtD
Dronabinol—Headache—Dexamethasone—multiple sclerosis	8.35e-05	0.00158	CcSEcCtD
Dronabinol—Headache—Betamethasone—multiple sclerosis	8.35e-05	0.00158	CcSEcCtD
Dronabinol—Asthenia—Prednisone—multiple sclerosis	8.33e-05	0.00157	CcSEcCtD
Dronabinol—Pruritus—Prednisone—multiple sclerosis	8.21e-05	0.00155	CcSEcCtD
Dronabinol—Feeling abnormal—Methotrexate—multiple sclerosis	7.99e-05	0.00151	CcSEcCtD
Dronabinol—Diarrhoea—Prednisone—multiple sclerosis	7.94e-05	0.0015	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.93e-05	0.0015	CcSEcCtD
Dronabinol—Dizziness—Prednisone—multiple sclerosis	7.67e-05	0.00145	CcSEcCtD
Dronabinol—Abdominal pain—Methotrexate—multiple sclerosis	7.67e-05	0.00145	CcSEcCtD
Dronabinol—Rash—Prednisone—multiple sclerosis	7.32e-05	0.00138	CcSEcCtD
Dronabinol—Dermatitis—Prednisone—multiple sclerosis	7.31e-05	0.00138	CcSEcCtD
Dronabinol—Headache—Prednisone—multiple sclerosis	7.27e-05	0.00137	CcSEcCtD
Dronabinol—Hypersensitivity—Methotrexate—multiple sclerosis	7.15e-05	0.00135	CcSEcCtD
Dronabinol—Asthenia—Methotrexate—multiple sclerosis	6.96e-05	0.00131	CcSEcCtD
Dronabinol—Pruritus—Methotrexate—multiple sclerosis	6.86e-05	0.00129	CcSEcCtD
Dronabinol—Diarrhoea—Methotrexate—multiple sclerosis	6.64e-05	0.00125	CcSEcCtD
Dronabinol—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	6.51e-05	0.00104	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	6.49e-05	0.00104	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—PTGER4—multiple sclerosis	6.45e-05	0.00103	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CXCL10—multiple sclerosis	6.42e-05	0.00103	CbGpPWpGaD
Dronabinol—Dizziness—Methotrexate—multiple sclerosis	6.41e-05	0.00121	CcSEcCtD
Dronabinol—CNR1—Signaling Pathways—RGS1—multiple sclerosis	6.41e-05	0.00103	CbGpPWpGaD
Dronabinol—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.37e-05	0.00102	CbGpPWpGaD
Dronabinol—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.34e-05	0.00102	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CXCR3—multiple sclerosis	6.23e-05	0.000997	CbGpPWpGaD
Dronabinol—Rash—Methotrexate—multiple sclerosis	6.11e-05	0.00115	CcSEcCtD
Dronabinol—Dermatitis—Methotrexate—multiple sclerosis	6.11e-05	0.00115	CcSEcCtD
Dronabinol—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.09e-05	0.000975	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CCL5—multiple sclerosis	6.09e-05	0.000974	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—GPR65—multiple sclerosis	6.08e-05	0.000972	CbGpPWpGaD
Dronabinol—Headache—Methotrexate—multiple sclerosis	6.08e-05	0.00115	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—CCR2—multiple sclerosis	6.06e-05	0.00097	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	6.04e-05	0.000967	CbGpPWpGaD
Dronabinol—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	5.98e-05	0.000956	CbGpPWpGaD
Dronabinol—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	5.98e-05	0.000956	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—POMC—multiple sclerosis	5.95e-05	0.000952	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.89e-05	0.000943	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.89e-05	0.000943	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CD86—multiple sclerosis	5.87e-05	0.000939	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.82e-05	0.000932	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CCL2—multiple sclerosis	5.82e-05	0.000932	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.8e-05	0.000928	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL10—multiple sclerosis	5.75e-05	0.00092	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	5.75e-05	0.00092	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL4—multiple sclerosis	5.6e-05	0.000895	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCL13—multiple sclerosis	5.56e-05	0.000889	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCR1—multiple sclerosis	5.56e-05	0.000889	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CXCL10—multiple sclerosis	5.55e-05	0.000888	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCL5—multiple sclerosis	5.53e-05	0.000884	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.51e-05	0.000882	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CCR5—multiple sclerosis	5.48e-05	0.000877	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	5.47e-05	0.000876	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—IL2RA—multiple sclerosis	5.4e-05	0.000865	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.34e-05	0.000854	CbGpPWpGaD
Dronabinol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.19e-05	0.000831	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.16e-05	0.000825	CbGpPWpGaD
Dronabinol—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.14e-05	0.000823	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.13e-05	0.00082	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.07e-05	0.000811	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL3—multiple sclerosis	5.05e-05	0.000808	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CXCL10—multiple sclerosis	5.04e-05	0.000806	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCR5—multiple sclerosis	4.98e-05	0.000797	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.92e-05	0.000787	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL2RA—multiple sclerosis	4.91e-05	0.000785	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PTGER4—multiple sclerosis	4.86e-05	0.000777	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PGR—multiple sclerosis	4.79e-05	0.000766	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCL5—multiple sclerosis	4.78e-05	0.000764	CbGpPWpGaD
Dronabinol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.73e-05	0.000757	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCR3—multiple sclerosis	4.69e-05	0.000751	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.66e-05	0.000746	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.66e-05	0.000746	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CD28—multiple sclerosis	4.65e-05	0.000744	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	4.63e-05	0.000741	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCR2—multiple sclerosis	4.57e-05	0.00073	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.54e-05	0.000726	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.53e-05	0.000724	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.44e-05	0.00071	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—SRM—multiple sclerosis	4.36e-05	0.000697	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCL5—multiple sclerosis	4.34e-05	0.000694	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCR5—multiple sclerosis	4.3e-05	0.000688	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—POMC—multiple sclerosis	4.29e-05	0.000686	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.28e-05	0.000685	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—IL2RA—multiple sclerosis	4.24e-05	0.000678	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.23e-05	0.000676	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.23e-05	0.000676	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.22e-05	0.000675	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CNR1—multiple sclerosis	4.21e-05	0.000674	CbGpPWpGaD
Dronabinol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.21e-05	0.000673	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—SRM—multiple sclerosis	4.18e-05	0.000669	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL3—multiple sclerosis	3.96e-05	0.000634	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—SRM—multiple sclerosis	3.96e-05	0.000633	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCR5—multiple sclerosis	3.91e-05	0.000625	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—POMC—multiple sclerosis	3.89e-05	0.000623	CbGpPWpGaD
Dronabinol—PTGS1—Biological oxidations—POMC—multiple sclerosis	3.88e-05	0.00062	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL2RA—multiple sclerosis	3.85e-05	0.000616	CbGpPWpGaD
Dronabinol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.84e-05	0.000614	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.82e-05	0.000611	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.82e-05	0.000611	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PTGER4—multiple sclerosis	3.81e-05	0.00061	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.81e-05	0.00061	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCL2—multiple sclerosis	3.81e-05	0.000609	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCL10—multiple sclerosis	3.79e-05	0.000607	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PGR—multiple sclerosis	3.76e-05	0.000601	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.73e-05	0.000597	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.7e-05	0.000593	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCR3—multiple sclerosis	3.68e-05	0.000589	CbGpPWpGaD
Dronabinol—CYP2A6—Biological oxidations—POMC—multiple sclerosis	3.67e-05	0.000587	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CD28—multiple sclerosis	3.65e-05	0.000584	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCR2—multiple sclerosis	3.58e-05	0.000573	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	3.57e-05	0.000571	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.48e-05	0.000557	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.48e-05	0.000557	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—TYK2—multiple sclerosis	3.46e-05	0.000553	CbGpPWpGaD
Dronabinol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.44e-05	0.000551	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.38e-05	0.000541	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—POMC—multiple sclerosis	3.36e-05	0.000538	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CD86—multiple sclerosis	3.32e-05	0.000531	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL5—multiple sclerosis	3.27e-05	0.000522	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—IL2—multiple sclerosis	3.17e-05	0.000507	CbGpPWpGaD
Dronabinol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.12e-05	0.0005	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—CYP27B1—multiple sclerosis	3.07e-05	0.000491	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—CYP24A1—multiple sclerosis	3.07e-05	0.000491	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—POMC—multiple sclerosis	3.05e-05	0.000489	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—SPP1—multiple sclerosis	3.02e-05	0.000484	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.02e-05	0.000483	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.01e-05	0.000481	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCL2—multiple sclerosis	2.99e-05	0.000478	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCL10—multiple sclerosis	2.98e-05	0.000476	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.97e-05	0.000476	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—SRM—multiple sclerosis	2.95e-05	0.000472	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—CYP27B1—multiple sclerosis	2.95e-05	0.000472	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—CYP24A1—multiple sclerosis	2.95e-05	0.000472	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCR5—multiple sclerosis	2.94e-05	0.000471	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL2RA—multiple sclerosis	2.9e-05	0.000464	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.89e-05	0.000462	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.88e-05	0.000461	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	2.88e-05	0.000461	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL2—multiple sclerosis	2.88e-05	0.00046	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GPC5—multiple sclerosis	2.81e-05	0.000449	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	2.79e-05	0.000446	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	2.79e-05	0.000446	CbGpPWpGaD
Dronabinol—CYP1A1—Biological oxidations—POMC—multiple sclerosis	2.73e-05	0.000437	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—TYK2—multiple sclerosis	2.71e-05	0.000434	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GPC5—multiple sclerosis	2.7e-05	0.000431	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—APOE—multiple sclerosis	2.68e-05	0.000428	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CD86—multiple sclerosis	2.6e-05	0.000416	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL5—multiple sclerosis	2.56e-05	0.00041	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.55e-05	0.000408	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.55e-05	0.000407	CbGpPWpGaD
Dronabinol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.53e-05	0.000405	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—IL2—multiple sclerosis	2.49e-05	0.000398	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CD80—multiple sclerosis	2.42e-05	0.000387	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—SRM—multiple sclerosis	2.41e-05	0.000386	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	2.41e-05	0.000386	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—SPP1—multiple sclerosis	2.37e-05	0.00038	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—SRM—multiple sclerosis	2.35e-05	0.000377	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.35e-05	0.000375	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—RRM1—multiple sclerosis	2.33e-05	0.000372	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCR5—multiple sclerosis	2.31e-05	0.000369	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—POMC—multiple sclerosis	2.3e-05	0.000368	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.28e-05	0.000365	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL2RA—multiple sclerosis	2.28e-05	0.000364	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL2—multiple sclerosis	2.26e-05	0.000361	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL2—multiple sclerosis	2.25e-05	0.00036	CbGpPWpGaD
Dronabinol—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.24e-05	0.000358	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—RRM1—multiple sclerosis	2.23e-05	0.000357	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—MAPK1—multiple sclerosis	2.2e-05	0.000352	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—SRM—multiple sclerosis	2.2e-05	0.000352	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.19e-05	0.00035	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—RRM1—multiple sclerosis	2.11e-05	0.000338	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—APOE—multiple sclerosis	2.1e-05	0.000336	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.000332	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.000332	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—TYK2—multiple sclerosis	2.04e-05	0.000327	CbGpPWpGaD
Dronabinol—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.04e-05	0.000326	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.03e-05	0.000325	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.02e-05	0.000323	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GPC5—multiple sclerosis	1.9e-05	0.000304	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CD80—multiple sclerosis	1.9e-05	0.000304	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—POMC—multiple sclerosis	1.8e-05	0.000289	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL2—multiple sclerosis	1.77e-05	0.000282	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.73e-05	0.000277	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—MAPK1—multiple sclerosis	1.73e-05	0.000276	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.7e-05	0.000272	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.7e-05	0.000272	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL2—multiple sclerosis	1.7e-05	0.000272	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL6—multiple sclerosis	1.69e-05	0.000271	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.66e-05	0.000266	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.66e-05	0.000265	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.66e-05	0.000265	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MMP9—multiple sclerosis	1.61e-05	0.000257	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—TYK2—multiple sclerosis	1.6e-05	0.000256	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—RRM1—multiple sclerosis	1.57e-05	0.000252	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.55e-05	0.000249	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.55e-05	0.000248	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.55e-05	0.000248	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GPC5—multiple sclerosis	1.52e-05	0.000243	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.51e-05	0.000242	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.49e-05	0.000238	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—SRM—multiple sclerosis	1.45e-05	0.000232	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—STAT3—multiple sclerosis	1.43e-05	0.000229	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.42e-05	0.000227	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.36e-05	0.000217	CbGpPWpGaD
Dronabinol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.34e-05	0.000215	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.34e-05	0.000215	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000214	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL2—multiple sclerosis	1.33e-05	0.000213	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MYC—multiple sclerosis	1.33e-05	0.000213	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL6—multiple sclerosis	1.33e-05	0.000212	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—TGFB1—multiple sclerosis	1.33e-05	0.000212	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MAPK1—multiple sclerosis	1.3e-05	0.000208	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.29e-05	0.000206	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000205	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MMP9—multiple sclerosis	1.26e-05	0.000202	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—RRM1—multiple sclerosis	1.26e-05	0.000201	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.22e-05	0.000195	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.21e-05	0.000194	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.17e-05	0.000188	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.16e-05	0.000186	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.16e-05	0.000185	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.13e-05	0.000182	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—STAT3—multiple sclerosis	1.12e-05	0.00018	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.08e-05	0.000173	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.05e-05	0.000168	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MYC—multiple sclerosis	1.04e-05	0.000167	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—TGFB1—multiple sclerosis	1.04e-05	0.000166	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.02e-05	0.000164	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.02e-05	0.000164	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MAPK1—multiple sclerosis	1.02e-05	0.000163	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.99e-06	0.00016	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL6—multiple sclerosis	9.99e-06	0.00016	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.57e-06	0.000153	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GPC5—multiple sclerosis	9.35e-06	0.00015	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.11e-06	0.000146	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—BCHE—multiple sclerosis	9.04e-06	0.000145	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.59e-06	0.000137	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—APOE—multiple sclerosis	8.04e-06	0.000129	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL6—multiple sclerosis	7.84e-06	0.000125	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.83e-06	0.000125	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.83e-06	0.000125	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.75e-06	0.000124	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—APOE—multiple sclerosis	7.72e-06	0.000124	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—BCHE—multiple sclerosis	7.4e-06	0.000118	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—APOE—multiple sclerosis	7.3e-06	0.000117	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.26e-06	0.000116	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—BCHE—multiple sclerosis	7.22e-06	0.000116	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.14e-06	0.000114	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—POMC—multiple sclerosis	6.9e-06	0.00011	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.75e-06	0.000108	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—POMC—multiple sclerosis	6.63e-06	0.000106	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ALB—multiple sclerosis	6.29e-06	0.000101	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—POMC—multiple sclerosis	6.27e-06	0.0001	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ALB—multiple sclerosis	6.05e-06	9.67e-05	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ALB—multiple sclerosis	5.72e-06	9.15e-05	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—APOE—multiple sclerosis	5.44e-06	8.7e-05	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—POMC—multiple sclerosis	4.67e-06	7.48e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—APOE—multiple sclerosis	4.45e-06	7.12e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.45e-06	7.12e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—APOE—multiple sclerosis	4.34e-06	6.95e-05	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ALB—multiple sclerosis	4.26e-06	6.82e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—APOE—multiple sclerosis	4.06e-06	6.49e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—POMC—multiple sclerosis	3.82e-06	6.12e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—POMC—multiple sclerosis	3.73e-06	5.97e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—POMC—multiple sclerosis	3.49e-06	5.58e-05	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ALB—multiple sclerosis	3.49e-06	5.58e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ALB—multiple sclerosis	3.4e-06	5.44e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ALB—multiple sclerosis	3.18e-06	5.09e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—APOE—multiple sclerosis	2.68e-06	4.28e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—POMC—multiple sclerosis	2.3e-06	3.68e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ALB—multiple sclerosis	2.1e-06	3.35e-05	CbGpPWpGaD
